Ignite Creation Date:
2024-05-06 @ 8:18 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06330064
Status:
RECRUITING
Last Update Posted:
2024-04-16
First Post:
2024-03-19
Brief Title:
A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan I-DXd In Subjects With Recurrent Or Metastatic Solid Tumors IDeate-PanTumor02
Sponsor:
Organization:
Daiichi Sankyo